CN Stock MarketDetailed Quotes

603087 Gan & Lee Pharmaceuticals.

Watchlist
  • 46.00
  • -0.16-0.35%
Market Closed Jul 12 15:00 CST
27.66BMarket Cap71.54P/E (TTM)

Gan & Lee Pharmaceuticals. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Gan & Lee Pharmaceuticals. Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 25, 2024

Revenue(YoY)

560.33M

+0.42%
EPS(YoY)

0.16

+77.78%
Analyst Rating

Strong Buy

Jul 12, 2024

Gan & Lee Pharmaceuticals. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.029B--
Aug 29, 20242024/Q2-- / 792.407M--
Apr 25, 20242024/Q1560.334M / 653.729M--
--2023/Q4702.366M / 698.815M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.029B--
Aug 29, 20242024/Q2-- / 792.407M--
Apr 25, 20242024/Q1560.334M / 653.729M--
--2023/Q4702.366M / 698.815M--
--------

Unlock Free Earnings Estimates

Gan & Lee Pharmaceuticals. Earnings Reports

  • Announcement of expected increase in performance for the first half of 2024.

    Jul 8 12:00 ET

  • 2023 ANNUAL REPORT

    Apr 24 12:00 ET

  • 2024 First Quarter Report

    Apr 24 12:00 ET

  • 2023 Annual Report Summary

    Apr 24 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 12, 2024

    Strong Buy

    • Strong Buy

      80.00%

    • Buy

      20.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg